Response to rituximab in children and adults with immune thrombocytopenia (ITP).
Emily M HarrisKirsty HillierDavid J KuterLaura BerbertRachael F F GracePublished in: Research and practice in thrombosis and haemostasis (2021)
Pre-rituximab immunologic evaluation varied significantly between adults and children, which could represent institution-specific practice patterns or a more general practice difference. If the latter, underlying immunodeficiency in adults with ITP may be underrecognized. Standardized guidance for pre-rituximab immunologic evaluation is needed.